E. Isoletta

Emergency accesses in Dermatology Department during the Covid‐19 pandemic in a referral third level center in the north of Italy

A. de Silvestri, S. Perlini, C. Vassallo, 2020, Dermatologic therapy.

SARS‐CoV‐2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

D. Lilleri, C. Vassallo, V. Brazzelli, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patients

A. Di Filippo, C. Vassallo, V. Brazzelli, 2021, JAAD case reports.

Does therapy with biological drugs influence COVID‐19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone

C. Klersy, C. Vassallo, V. Brazzelli, 2020, Dermatologic therapy.

Dynamics of humoral and cellular immunity elicited by the BNT162b2 mRNA vaccine in psoriatic patients under targeted immunosuppression: A longitudinal cohort study

F. Baldanti, D. Lilleri, C. Klersy, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

An atypical presentation of tuberculous gumma heralding a diagnosis of lymph node tuberculosis: Hindsight is 20/20

V. Brazzelli, M. Sachs, A. Bonometti, 2022, JAAD Case Reports.

Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline

T. Foiadelli, S. Savasta, V. Brazzelli, 2022, Dermatologic therapy.

A case of pediatric indolent systemic mastocytosis: The role of UVB-NB phototherapy in the treatment of cutaneous lesions.

V. Brazzelli, E. Boveri, G. Bossi, 2023, Photodermatology, photoimmunology & photomedicine.

A Clinico-Pathological Multidisciplinary Team Increases the Efficacy of Skin Biopsy and Reduces Clinical Risk in Dermatology

A. Muzzi, C. Tomasini, Barbara Wade, 2023, Dermatopathology.

Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine

S. Barruscotti, E. Isoletta, M. Volonté, 2024, Frontiers in immunology.